VE303 clinical trials

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

This study is testing a new medicine, VE303, to prevent repeated C. diff infections. C. diff causes severe diarrhoea. We want to see if VE303 is safe and helps stop the infection from coming back after standard treatment.